OmniComm Systems Buys EDC Business of eResearchTechnology

Wednesday, June 24, 2009 11:07 AM

Fort Lauderdale, Fla.-based OmniComm Systems, a clinical trials electronic data capture (EDC) solutions company and eResearchTechnology (ERT), a global provider of cardiac safety and clinical data, announced that OmniComm has acquired the EDC business of ERT.

Revenues for ERT's EDC business were $5.9 million in the year ended December 31, 2008, and $1.4 million in the three months ended March 31, 2009.

Under the terms of the transaction, OmniComm issued 8.1 million shares of common stock and assumed certain liabilities including deferred revenue relating to ERT's EDC business in exchange for the EDC assets of ERT, which primarily include its EDC software, applications, and fixed assets, and $1.15 million in cash paid by ERT. OmniComm's shares last traded over-the-counter at 25 cents a share.

OmniComm will be opening a new branch office in the New Jersey area and will be transitioning the majority of the ERT's EDC support team to this new office to provide on-going support and maintenance to the ERT customers.

"We believe strongly in the long-term growth of the EDC and eClinical markets. We have positioned ourselves to be a leading provider of EDC solutions and expect this transaction to allow us to grow more rapidly. By combining the two EDC businesses, OmniComm extends and deepens its roster of EDC customers and gains several key technologies," stated Cornelis F. Wit, CEO of OmniComm Systems.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs